 | • レポートコード：GIR-107A14934 • 出版社/出版日：GlobalInfoResearch / 2021年7月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、二重特異性抗体薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。二重特異性抗体薬の種類別市場規模（フラグメント、IgG）、用途別市場規模（がん、血友病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・二重特異性抗体薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Amgen、Sanofi、Pfizer、Johnson & Johnson、AstraZeneca、Abbvie、Lindis Biotech、MacroGenics、Genmab、Immunocore Limited、Xencor、Merck、Affimed、Alphamab、Akeso、BeiGene ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：フラグメント、IgG ・用途別分析2016年-2026年：がん、血友病、その他 ・二重特異性抗体薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・二重特異性抗体薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・二重特異性抗体薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・二重特異性抗体薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・二重特異性抗体薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bispecific Antibody Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bispecific Antibody Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Bispecific Antibody Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bispecific Antibody Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fragment-Based
IgG-Based
Market segment by Application, can be divided into
Cancer
Haemophilia
Other Diseases
Market segment by players, this report covers
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
Abbvie
Lindis Biotech
MacroGenics
Genmab
Immunocore Limited
Xencor
Merck
Affimed
Alphamab
Akeso
BeiGene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Bispecific Antibody Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Bispecific Antibody Drug, with revenue, gross margin and global market share of Bispecific Antibody Drug from 2019 to 2021.
Chapter 3, the Bispecific Antibody Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Bispecific Antibody Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Bispecific Antibody Drug research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Bispecific Antibody Drug
1.2 Classification of Bispecific Antibody Drug by Type
1.2.1 Overview: Global Bispecific Antibody Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Bispecific Antibody Drug Revenue Market Share by Type in 2020
1.2.3 Fragment-Based
1.2.4 IgG-Based
1.3 Global Bispecific Antibody Drug Market by Application
1.3.1 Overview: Global Bispecific Antibody Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Diseases
1.4 Global Bispecific Antibody Drug Market Size & Forecast
1.5 Global Bispecific Antibody Drug Market Size and Forecast by Region
1.5.1 Global Bispecific Antibody Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Bispecific Antibody Drug Market Size by Region, (2016-2021)
1.5.3 North America Bispecific Antibody Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Bispecific Antibody Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Bispecific Antibody Drug Market Size and Prospect (2016-2026)
1.5.6 South America Bispecific Antibody Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Bispecific Antibody Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bispecific Antibody Drug Market Drivers
1.6.2 Bispecific Antibody Drug Market Restraints
1.6.3 Bispecific Antibody Drug Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Bispecific Antibody Drug Product and Solutions
2.1.4 Roche Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Bispecific Antibody Drug Product and Solutions
2.2.4 Amgen Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Bispecific Antibody Drug Product and Solutions
2.3.4 Sanofi Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Bispecific Antibody Drug Product and Solutions
2.4.4 Pfizer Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Bispecific Antibody Drug Product and Solutions
2.5.4 Johnson & Johnson Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Bispecific Antibody Drug Product and Solutions
2.6.4 AstraZeneca Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Bispecific Antibody Drug Product and Solutions
2.7.4 Abbvie Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Lindis Biotech
2.8.1 Lindis Biotech Details
2.8.2 Lindis Biotech Major Business
2.8.3 Lindis Biotech Bispecific Antibody Drug Product and Solutions
2.8.4 Lindis Biotech Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Lindis Biotech Recent Developments and Future Plans
2.9 MacroGenics
2.9.1 MacroGenics Details
2.9.2 MacroGenics Major Business
2.9.3 MacroGenics Bispecific Antibody Drug Product and Solutions
2.9.4 MacroGenics Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 MacroGenics Recent Developments and Future Plans
2.10 Genmab
2.10.1 Genmab Details
2.10.2 Genmab Major Business
2.10.3 Genmab Bispecific Antibody Drug Product and Solutions
2.10.4 Genmab Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Genmab Recent Developments and Future Plans
2.11 Immunocore Limited
2.11.1 Immunocore Limited Details
2.11.2 Immunocore Limited Major Business
2.11.3 Immunocore Limited Bispecific Antibody Drug Product and Solutions
2.11.4 Immunocore Limited Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Immunocore Limited Recent Developments and Future Plans
2.12 Xencor
2.12.1 Xencor Details
2.12.2 Xencor Major Business
2.12.3 Xencor Bispecific Antibody Drug Product and Solutions
2.12.4 Xencor Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Xencor Recent Developments and Future Plans
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business
2.13.3 Merck Bispecific Antibody Drug Product and Solutions
2.13.4 Merck Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Merck Recent Developments and Future Plans
2.14 Affimed
2.14.1 Affimed Details
2.14.2 Affimed Major Business
2.14.3 Affimed Bispecific Antibody Drug Product and Solutions
2.14.4 Affimed Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Affimed Recent Developments and Future Plans
2.15 Alphamab
2.15.1 Alphamab Details
2.15.2 Alphamab Major Business
2.15.3 Alphamab Bispecific Antibody Drug Product and Solutions
2.15.4 Alphamab Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Alphamab Recent Developments and Future Plans
2.16 Akeso
2.16.1 Akeso Details
2.16.2 Akeso Major Business
2.16.3 Akeso Bispecific Antibody Drug Product and Solutions
2.16.4 Akeso Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Akeso Recent Developments and Future Plans
2.17 BeiGene
2.17.1 BeiGene Details
2.17.2 BeiGene Major Business
2.17.3 BeiGene Bispecific Antibody Drug Product and Solutions
2.17.4 BeiGene Bispecific Antibody Drug Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 BeiGene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Bispecific Antibody Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Bispecific Antibody Drug Players Market Share
3.2.2 Top 10 Bispecific Antibody Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Bispecific Antibody Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Bispecific Antibody Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Bispecific Antibody Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Bispecific Antibody Drug Revenue Market Share by Application (2016-2021)
5.2 Bispecific Antibody Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Bispecific Antibody Drug Revenue by Type (2016-2026)
6.2 North America Bispecific Antibody Drug Revenue by Application (2016-2026)
6.3 North America Bispecific Antibody Drug Market Size by Country
6.3.1 North America Bispecific Antibody Drug Revenue by Country (2016-2026)
6.3.2 United States Bispecific Antibody Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Bispecific Antibody Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Bispecific Antibody Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Bispecific Antibody Drug Revenue by Type (2016-2026)
7.2 Europe Bispecific Antibody Drug Revenue by Application (2016-2026)
7.3 Europe Bispecific Antibody Drug Market Size by Country
7.3.1 Europe Bispecific Antibody Drug Revenue by Country (2016-2026)
7.3.2 Germany Bispecific Antibody Drug Market Size and Forecast (2016-2026)
7.3.3 France Bispecific Antibody Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Bispecific Antibody Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Bispecific Antibody Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Bispecific Antibody Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Bispecific Antibody Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Bispecific Antibody Drug Market Size by Region
8.3.1 Asia-Pacific Bispecific Antibody Drug Revenue by Region (2016-2026)
8.3.2 China Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8.3.5 India Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Bispecific Antibody Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Bispecific Antibody Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Bispecific Antibody Drug Revenue by Type (2016-2026)
9.2 South America Bispecific Antibody Drug Revenue by Application (2016-2026)
9.3 South America Bispecific Antibody Drug Market Size by Country
9.3.1 South America Bispecific Antibody Drug Revenue by Country (2016-2026)
9.3.2 Brazil Bispecific Antibody Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Bispecific Antibody Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Bispecific Antibody Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Bispecific Antibody Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Bispecific Antibody Drug Market Size by Country
10.3.1 Middle East & Africa Bispecific Antibody Drug Revenue by Country (2016-2026)
10.3.2 Turkey Bispecific Antibody Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Bispecific Antibody Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Bispecific Antibody Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Bispecific Antibody Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Bispecific Antibody Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Bispecific Antibody Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Bispecific Antibody Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Bispecific Antibody Drug Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Bispecific Antibody Drug Product and Solutions
Table 9. Roche Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Bispecific Antibody Drug Product and Solutions
Table 13. Amgen Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Bispecific Antibody Drug Product and Solutions
Table 17. Sanofi Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Bispecific Antibody Drug Product and Solutions
Table 21. Pfizer Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Bispecific Antibody Drug Product and Solutions
Table 25. Johnson & Johnson Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Bispecific Antibody Drug Product and Solutions
Table 29. AstraZeneca Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Abbvie Corporate Information, Head Office, and Major Competitors
Table 31. Abbvie Major Business
Table 32. Abbvie Bispecific Antibody Drug Product and Solutions
Table 33. Abbvie Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Lindis Biotech Corporate Information, Head Office, and Major Competitors
Table 35. Lindis Biotech Major Business
Table 36. Lindis Biotech Bispecific Antibody Drug Product and Solutions
Table 37. Lindis Biotech Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. MacroGenics Corporate Information, Head Office, and Major Competitors
Table 39. MacroGenics Major Business
Table 40. MacroGenics Bispecific Antibody Drug Product and Solutions
Table 41. MacroGenics Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Genmab Corporate Information, Head Office, and Major Competitors
Table 43. Genmab Major Business
Table 44. Genmab Bispecific Antibody Drug Product and Solutions
Table 45. Genmab Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Immunocore Limited Corporate Information, Head Office, and Major Competitors
Table 47. Immunocore Limited Major Business
Table 48. Immunocore Limited Bispecific Antibody Drug Product and Solutions
Table 49. Immunocore Limited Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Xencor Corporate Information, Head Office, and Major Competitors
Table 51. Xencor Major Business
Table 52. Xencor Bispecific Antibody Drug Product and Solutions
Table 53. Xencor Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Merck Corporate Information, Head Office, and Major Competitors
Table 55. Merck Major Business
Table 56. Merck Bispecific Antibody Drug Product and Solutions
Table 57. Merck Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Affimed Corporate Information, Head Office, and Major Competitors
Table 59. Affimed Major Business
Table 60. Affimed Bispecific Antibody Drug Product and Solutions
Table 61. Affimed Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Alphamab Corporate Information, Head Office, and Major Competitors
Table 63. Alphamab Major Business
Table 64. Alphamab Bispecific Antibody Drug Product and Solutions
Table 65. Alphamab Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Akeso Corporate Information, Head Office, and Major Competitors
Table 67. Akeso Major Business
Table 68. Akeso Bispecific Antibody Drug Product and Solutions
Table 69. Akeso Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. BeiGene Corporate Information, Head Office, and Major Competitors
Table 71. BeiGene Major Business
Table 72. BeiGene Bispecific Antibody Drug Product and Solutions
Table 73. BeiGene Bispecific Antibody Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Bispecific Antibody Drug Revenue (USD Million) by Players (2019-2021)
Table 75. Global Bispecific Antibody Drug Revenue Share by Players (2019-2021)
Table 76. Breakdown of Bispecific Antibody Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Bispecific Antibody Drug Players Head Office, Products and Services Provided
Table 78. Bispecific Antibody Drug Mergers & Acquisitions in the Past Five Years
Table 79. Bispecific Antibody Drug New Entrants and Expansion Plans
Table 80. Global Bispecific Antibody Drug Revenue (USD Million) by Type (2016-2021)
Table 81. Global Bispecific Antibody Drug Revenue Share by Type (2016-2021)
Table 82. Global Bispecific Antibody Drug Revenue Forecast by Type (2021-2026)
Table 83. Global Bispecific Antibody Drug Revenue by Application (2016-2021)
Table 84. Global Bispecific Antibody Drug Revenue Forecast by Application (2021-2026)
Table 85. North America Bispecific Antibody Drug Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Bispecific Antibody Drug Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Bispecific Antibody Drug Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Bispecific Antibody Drug Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Bispecific Antibody Drug Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Bispecific Antibody Drug Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Bispecific Antibody Drug Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Bispecific Antibody Drug Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Bispecific Antibody Drug Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Bispecific Antibody Drug Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Bispecific Antibody Drug Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Bispecific Antibody Drug Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Bispecific Antibody Drug Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Bispecific Antibody Drug Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Bispecific Antibody Drug Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Bispecific Antibody Drug Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Bispecific Antibody Drug Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Bispecific Antibody Drug Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Bispecific Antibody Drug Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Bispecific Antibody Drug Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Bispecific Antibody Drug Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Bispecific Antibody Drug Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Bispecific Antibody Drug Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Bispecific Antibody Drug Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Bispecific Antibody Drug Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Bispecific Antibody Drug Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Bispecific Antibody Drug Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Bispecific Antibody Drug Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Bispecific Antibody Drug Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Bispecific Antibody Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Bispecific Antibody Drug Picture
Figure 2. Global Bispecific Antibody Drug Revenue Market Share by Type in 2020
Figure 3. Fragment-Based
Figure 4. IgG-Based
Figure 5. Bispecific Antibody Drug Revenue Market Share by Application in 2020
Figure 6. Cancer Picture
Figure 7. Haemophilia Picture
Figure 8. Other Diseases Picture
Figure 9. Global Bispecific Antibody Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Bispecific Antibody Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Bispecific Antibody Drug Revenue Market Share by Region (2016-2026)
Figure 12. Global Bispecific Antibody Drug Revenue Market Share by Region in 2020
Figure 13. North America Bispecific Antibody Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Bispecific Antibody Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Bispecific Antibody Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Bispecific Antibody Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Bispecific Antibody Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Bispecific Antibody Drug Market Drivers
Figure 19. Bispecific Antibody Drug Market Restraints
Figure 20. Bispecific Antibody Drug Market Trends
Figure 21. Roche Recent Developments and Future Plans
Figure 22. Amgen Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Pfizer Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. AstraZeneca Recent Developments and Future Plans
Figure 27. Abbvie Recent Developments and Future Plans
Figure 28. Lindis Biotech Recent Developments and Future Plans
Figure 29. MacroGenics Recent Developments and Future Plans
Figure 30. Genmab Recent Developments and Future Plans
Figure 31. Immunocore Limited Recent Developments and Future Plans
Figure 32. Xencor Recent Developments and Future Plans
Figure 33. Merck Recent Developments and Future Plans
Figure 34. Affimed Recent Developments and Future Plans
Figure 35. Alphamab Recent Developments and Future Plans
Figure 36. Akeso Recent Developments and Future Plans
Figure 37. BeiGene Recent Developments and Future Plans
Figure 38. Global Bispecific Antibody Drug Revenue Share by Players in 2020
Figure 39. Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Bispecific Antibody Drug Revenue Market Share in 2020
Figure 41. Global Top 10 Players Bispecific Antibody Drug Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Bispecific Antibody Drug Revenue Share by Type in 2020
Figure 44. Global Bispecific Antibody Drug Market Share Forecast by Type (2021-2026)
Figure 45. Global Bispecific Antibody Drug Revenue Share by Application in 2020
Figure 46. Global Bispecific Antibody Drug Market Share Forecast by Application (2021-2026)
Figure 47. North America Bispecific Antibody Drug Sales Market Share by Type (2016-2026)
Figure 48. North America Bispecific Antibody Drug Sales Market Share by Application (2016-2026)
Figure 49. North America Bispecific Antibody Drug Revenue Market Share by Country (2016-2026)
Figure 50. United States Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Bispecific Antibody Drug Sales Market Share by Type (2016-2026)
Figure 54. Europe Bispecific Antibody Drug Sales Market Share by Application (2016-2026)
Figure 55. Europe Bispecific Antibody Drug Revenue Market Share by Country (2016-2026)
Figure 56. Germany Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Bispecific Antibody Drug Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Bispecific Antibody Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Bispecific Antibody Drug Revenue Market Share by Region (2016-2026)
Figure 64. China Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Bispecific Antibody Drug Sales Market Share by Type (2016-2026)
Figure 71. South America Bispecific Antibody Drug Sales Market Share by Application (2016-2026)
Figure 72. South America Bispecific Antibody Drug Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Bispecific Antibody Drug Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Bispecific Antibody Drug Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Bispecific Antibody Drug Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Bispecific Antibody Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source